The company from Israel will develop their blockchain-secured healthcare data exchange platform further.
Briya, an Israeli-based company, just raised $11.5M in a Series A funding. It will support the expansion of its health care data exchange platform across Europe and the U.S.
The round was led by Team8, includes existing investors Insight Partners and Amiti Ventures, and is joined by the George Kaiser Family Foundation. It brings the company’s total funding to $17 million.
Increasing and accelerating access to clinical data
Briya connects clinics and hospitals with academic and pharmaceutical research teams, in a bid to optimize clinical trials, ensure regulatory compliance, and accelerate drug discovery.
The company’s scalable data exchange platform enables hospitals to capitalize on their patient data. It has been implemented in healthcare systems and academic institutions, primarily in Europe and Israel.
Congratulations to the Briya team, who is currently participating in our DayOne Health 4.0 accelerator.
Read more here.
Secure platform for harmonized data
Headquartered in Tel Aviv, Briya Labs LTD, is making healthcare data from hospitals easily accessible by pharma and academia, to drive health R&D and innovation.
The company developed a scalable and secure platform that enables real-time retrieval and sharing of high-quality harmonized longitudinal data in the most seamless way possible.
Their decentralized solution provides fast and secure access to longitudinal patient-level data that has been unified and matched across sources (EMR, PACS, pathological, etc.) to speed up development cycles, shorten time to medicine and enable companies to reach bigger and more relevant markets.
About the DayOne Health 4.0 accelerator
DayOne Health 4.0 is a six-month hybrid accelerator in the Basel Area, Europe’s healthcare hub. Get support for innovating across the healthcare spectrum, from diagnosis to prevention, patient and caregiver communication and solutions for healthcare professionals.
The 2023 edition, running from September 2023 to March 2024, focuses on Artificial Intelligence, data and digitally enhanced clinical development.